• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE S; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK RELIANCE S; IMPLANTABLE LEAD Back to Search Results
Model Number 0137
Medical Device Problem Code High Capture Threshold (3266)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/16/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during a routine follow-up, this right ventricular (rv) lead exhibited high pacing thresholds.Fluoroscopy imaging was performed, and it was discovered that the lead position was the cause of the high pacing thresholds.The rv lead was explanted and successfully replaced with a new lead.No additional adverse patient effects were reported.The lead is expected to return.
 
Event or Problem Description
It was reported that during a routine follow-up, this right ventricular (rv) lead exhibited high pacing thresholds.Fluoroscopy imaging was performed, and it was discovered that the lead position was the cause of the high pacing thresholds.The rv lead was explanted and successfully replaced with a new lead.No additional adverse patient effects were reported.This lead was returned, and analysis was performed.
 
Additional Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the lead was performed.Testing was completed to assess lead electrical performance and inner and outer insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, and electrode tip found no anomalies.Dried body fluid and tissue were noted in the helix housing which is normal for active fixation leads.Laboratory testing was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE S
Common Device Name
IMPLANTABLE LEAD
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
road 698, lot no. 12
dorado PR 00646 -260
*   00646-2602
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17185690
Report Number2124215-2023-32534
Device Sequence Number6495010
Product Code LWS
UDI-Device Identifier00802526531101
UDI-Public00802526531101
Combination Product (Y/N)Y
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P910073/S039
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Device Explanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/10/2023
Device Model Number0137
Device Catalogue Number0137
Device Lot Number301143
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 06/16/2023
Supplement Date Received by Manufacturer08/31/2023
Initial Report FDA Received Date06/22/2023
Supplement Report FDA Received Date09/20/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/10/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age28 YR
Patient SexMale
-
-